Cleared Traditional

K910279 - MCSEER/MICRO CONTROLLER SLD ST EEG EVENT RECORDER

K910279 is an FDA 510(k) clearance for MCSEER/MICRO CONTROLLER SLD ST EEG EVEN..., manufactured by New England Medical Instruments, Inc.. The device is a Class 2 Neurology device with product code GWQ cleared through the Traditional 510(k) pathway after a 224-day FDA review.

K910279 · New England Medical Instruments, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1991
Decision
224d
Days
Class 2
Risk

K910279 is an FDA 510(k) clearance for the MCSEER/MICRO CONTROLLER SLD ST EEG EVENT RECORDER. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by New England Medical Instruments, Inc. (Lexington, US). The FDA issued a Cleared decision on September 4, 1991 after a review of 224 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all New England Medical Instruments, Inc. devices

FDA 510(k) Submission Details - K910279

510(k) Number K910279 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 1991
Decision Date September 04, 1991
Days to Decision 224 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
76d slower than avg
Panel avg: 148d · This submission: 224d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWQ Device Classification - Class 2, Special Controls

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 132
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K910279.
THE GALILEO VEGA-24 ELECTROENCEPHALOGRAPH
K923950 · Biosound, Inc. · Jan 1993
NEUROFAX EEG 5532
K915096 · Nihon Kohden America, Inc. · Mar 1992
PHOENIX DIGITAL EEG SYSTEM
K911229 · Dantec Medical, Inc. · Sep 1991
HORIZON 2000 EEG MONITORING OPTION
K910945 · Mennen Medical, Inc. · Aug 1991
MENTOR EEG SYSTEM
K904763 · Oxford Medilog, Inc. · Apr 1991
EEG-5400 SERIES
K902550 · Nihon Kohden America, Inc. · Mar 1991